story of the week
Rondoraptivon Pegol Increases Platelet Counts and VWF/FVIII Levels in Type 2B von Willebrand Disease
Sign in to PracticeUpdate
Only registered members have full access to PracticeUpdate content.
Additional Info
Disclosure statements are available on the authors' profiles:
Blood Advances
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.
The VWF binding aptamer rondoraptivon pegol increases platelet counts and VWF/FVIII in type 2B von Willebrand disease
Blood Adv 2022 Jun 30;[EPub Ahead of Print], C Ay, I Pabinger, KD Kovacevic, G Gelbenegger, C Schoergenhofer, P Quehenberger, P Jilma-Stohlawetz, R Sunder-Plaßmann, JC Gilbert, S Zhu, B Jilma, U DerhaschnigFrom MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.